Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)
Open Access
- 19 November 2025
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 210, 108840
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca plc
- Princess Margaret Cancer Foundation
This publication has 39 references indexed in Scilit:
- MA16.06 Real-world Survival with CRT+durvalumab for Unresectable, Stage III NSCLC in Canada: the RELEVANCE StudyJournal of Thoracic Oncology, 2023
- Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Annals of Oncology, 2021
- Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic reviewCancer Treatment Reviews, 2020
- Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancerClinical and Translational Oncology, 2017
- The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2016
- Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer ConsortiumEBioMedicine, 2015
- Small cell lung cancer: Where do we go from here?Cancer, 2014
- Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results databaseLung Cancer, 2009
- Staging and prognostic factors in small cell lung cancer: a consensus reportLung Cancer, 1989
- Small-cell carcinoma of the lung—survival according to histologic subtype: A veterans administration lung group studyCancer, 1981